Iowa Administrative Code › Agency 645 - Professional Licensure Division › Psychologists › Chapter 244 - Prescribing Psychologists › Rule 645-244.8 - Collaborative Practice-joint Rule

Current through Register Vol. 47, No. 3, July 24, 2024
(1) A prescribing psychologist shall have one
				or more collaborating physicians at all times, as evidenced by a current
				collaborative practice agreement. Prior to executing a collaborative practice
				agreement, a prescribing psychologist and a collaborating physician shall
				review and discuss each other's relevant education, training, experience, and
				competencies to determine whether a collaborative practice is appropriate and
				to facilitate drafting a suitable collaborative practice agreement. A
				collaborative relationship between a prescribing psychologist and a
				collaborating physician shall ensure patient safety and optimal clinical
				outcomes. Collaboration may be done in person or via electronic communication
				in accordance with these rules. A physician shall not serve as a collaborating
				physician for more than two prescribing psychologists at one time. A
				prescribing psychologist shall not prescribe without a current written
				collaborative practice agreement with a collaborating physician in place. All
				collaborative relationships shall be reviewed and evaluated on an annual basis
				to ensure that the prescribing psychologist is competent to safely prescribe
				psychotropic medications to patients and that the collaborating physician is
				providing appropriate feedback to the prescribing psychologist. A collaborative
				practice agreement shall establish the parameters of the collaborative practice
				that are mutually agreed upon by the prescribing psychologist and the
				collaborating physician and shall be reviewed on an annual basis.
(2) A collaborative practice agreement shall
				include the following:
a.
Prescribing
				psychologist information.
The name, license number, DEA registration
				number, CSA registration number, address, telephone number, email address, and
				practice locations of the prescribing psychologist.
b.
Collaborating physician
				information.
The name, license number, DEA registration number, CSA
				registration number, address, telephone number, email address, and practice
				locations of the collaborating physician.
c.
Time period.
The time
				period covered by the agreement.
d.
Locations and settings.
The locations and settings where
				collaborative practice will occur.
e.
Collaboration.
A
				provision indicating that the collaborating physician and prescribing
				psychologist shall ensure that the collaborating physician is available for
				timely collaboration with a prescribing psychologist, either in person or via
				electronic communication, in accordance with these rules.
f.
Scope of practice.
The
				scope of practice agreed upon by the collaborating physician and the
				prescribing psychologist, as it relates to the prescribing psychologist's
				prescribing of psychotropic medications, including provisions to ensure that
				the prescribing psychologist's practice complies with all provisions of these
				rules.
g.
Clinical
				protocols, practice guidelines, and care plans.
Clinical protocols,
				practice guidelines, and care plans relevant to the scope of practice
				authorized.
h.
Methods of
				communication.
A description of how a prescribing psychologist and a
				collaborating physician may contact each other for consultation.
i.
Limitations on psychotropic
				medications.
A description of any limitations on the range of
				psychotropic medications the prescribing psychologist may prescribe. The
				collaborative practice agreement shall also include a provision indicating that
				the collaborating physician and prescribing psychologist shall ensure that the
				prescribing psychologist only prescribes psychotropic medications that are
				consistent with the prescribing psychologist's education, training, experience,
				and competence.
j.
Limitations on patient populations.
A description of any
				limitations on the types of populations that the prescribing psychologist may
				treat with psychotropic medications. The collaborative practice agreement shall
				also include a provision indicating that the collaborating physician and
				prescribing psychologist shall ensure that the prescribing psychologist only
				provides psychopharmacology services to patient populations that are within the
				prescribing psychologist's education, training, experience, and
				competence.
k.
Release of
				information.
A provision requiring the prescribing psychologist to
				obtain a release of information from all patients who are considered for
				psychopharmacological intervention, authorizing the prescribing psychologist to
				share the patient's health information with the collaborating
				physician.
l.
Chart
				review.
A provision indicating that the collaborating physician and
				prescribing psychologist shall ensure that the collaborative physician
				personally reviews and documents review of at least 10 percent of the
				prescribing psychologist's patient charts on a quarterly basis in each of the
				following categories:
(1) Juvenile
				patients,
(2) Pregnant or lactating
				patients,
(3) Elderly
				patients,
(4) Patients with serious
				medical conditions, and
(5) All
				other patients.
m.
Annual review.
A provision requiring an annual review and
				evaluation of the collaborative relationship and the collaborative practice
				agreement.
n.
Consultation
				between the prescribing psychologist and the collaborating physician.
A provision requiring that the prescribing psychologist consult with the
				collaborating physician on a regular basis regarding the patient's psychotropic
				treatment plan and any potential complications. A prescribing psychologist
				shall not prescribe a new psychotropic medication, discontinue a psychotropic
				medication, or change the dosage of a psychotropic medication if the
				collaborating physician objects on the basis of a contraindication.
o.
Consultation between the
				collaborating physician and the primary care provider.
A provision
				requiring that the collaborating physician consult with the patient's primary
				care provider on a regular basis regarding the patient's psychotropic treatment
				plan and any potential complications.
p.
Termination.
A provision
				describing how the agreement can be terminated and the process for notifying
				affected patients if there will be an interruption in services.
q.
Signatures.
Signatures of
				the prescribing psychologist and all collaborating physicians.